Vol 2003, No 36 (2003)

Table of Contents

Research & Development

Schering and Astex Enter Multi-target Drug Discovery Alliance Abstract pdf
Business Review Editor
Allergen and Acadia Enter Third Drug Discovery Collaboration Abstract pdf
Business Review Editor

Licensing

Guilford Licenses Neurological Drugs to Pfizer Abstract pdf
Business Review Editor
GSK and Neose in Vaccine Deal Abstract pdf
Business Review Editor

General

Shire and Noven in ADHD Deal Abstract
Business Review Editor
Celltech, Oxford GlycoSciences and the Bidding War That Never Was Abstract
Business Review Editor
Therapy Focus: Psoriasis Abstract
Business Review Editor

Mergers & Acquisitions

Quintiles moves from Public to Private via cash Merger Abstract pdf
Business Review Editor

Company Profile

Leo Pharma A/S Abstract pdf
Business Review Editor

Distribution & Marketing

Novo Nordisk and Fournier Pharma Sign Co-Marketing Agreement for Repaglinide in Europe Abstract pdf
Business Review Editor
Eyetech Pharmaceuticals Enters Deal to Market Pfizer’s Xalatan® Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.